michelcarroll/llama2-earnings-stock-prediction-fine-tune huggingface dataset:
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
I'll relate to that, Steve. So, this collaboration -- actually this expansion of the collaboration reflects on the long-term -- long-standing relationship between the two companies. It is -- it stands for itself. It is really designed in order to enhance the strategic collaboration. It is enhanced -- it is designed to support the kind of studies that we have, to support Compugen in executing these studies. At this point in time, we are on the strategy front of -- on the clinical strategy front. We are at the stage that we completed all the dose escalation studies that we wanted to do and we already started the expansion cohort. And remember that we have with Bristol now two combination studies. The COM701 [Phonetic] nivolumab and the triplet and each of the study is conducted in multiple tumor types. We have broadly translational program that this with PD markers and immunohistochemistry, as we stated in the past also, that we're trying invest technology on our patient-center. So, the collaboration is actually growing and growing, and both parties felt that it would be good to have a Joint Strategic Oversight Committee that is actually working in parallel to the Joint Development Committee that is working at the operational level. So at this point in time, having all studies being expanded, that's the right time for us to align on the strategy of how we're interpreting the data together, and how we think about next step.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Thank you for the questions Kumar. So we are in process for this ranking exercise in solid tumors. What I can tell you, I'll tell you some examples that we're considering and these are, they're not a finalist yet but they're in the running. So ovarian cancer combined with potentially Taxol or Platinum is a possibility.
Lung cancer, combined with OC ibrutinib is a possibility. Breast cancer combined with paclitaxel remain something that we're quite interested in and so I think those are examples where ROR1 expression is high in the tumor. ROR1 activity has been demonstrated and cirmtuzumab activity is has been demonstrated in preclinical models. And so there that makes them all interesting to us.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Hey. Good evening, gentlemen, and thanks for taking the question, and congrats on a really strong result. So first one, I don't know if Brent or R.A. wants to take this.
I heard a lot of drivers of the ARR acceleration, but I did hear that net new picked up. And I'm curious if you could double click on that a bit. Was that win rates picking up, you know, bigger pipeline of opportunities, you know, any increased share donors? Any thoughts on that?

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes, there was an element of that coming through as well. That moved our benefit ratio by about 1.5 points down.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes. As you said, we think that the immunocompromised population which, as I'm sure you all know, represents 3% to 4% of the U.S. population, that several million individuals, a variety of studies are showing that somewhere around 50% or more of these individuals do not respond after two or even after three attempts with the vaccine. And so these people are left without their own antibodies to protect them. So it's a huge unmet need setting where these individuals will not be protected. And as we're all seeing that it's very unlikely that we will be eliminating spread of infections through breakthrough infections, whether it was symptomatic or otherwise throughout the population for these individuals to be able to live normal lives they're going to need protection.
And we believe that the most powerful protection is essentially providing them with these surrogate antibodies that our antibody cocktail provides. We already have very strong data, we believe, to support the notion that this agent can be used in chronic prevention settings, and we do intend to continue to explore future study opportunities where we can further enhance on the already existing data that shows that after the first week or so, we seem to obtain similar upwards of 90% protection against infection in individuals who do not have their own antibodies and are being exposed to the SARS-CoV-2 virus. I think that is very strong data that bodes very well that this is potentially to be a very important treatment, particularly for these immunocompromised individuals who do not have antibodies of their own.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Hi, guys. Thanks for taking my call. First, I want to offer my congratulations as well to both Nate and James. Nate, on your second shift to the role of Executive Chairman and James, I can't think of another person better suited to taking on the CEO role. And then furthermore, I'm happy to hear that no material changes in course are planned going forward. I, too, am getting lots of questions from investors about fiscal 2022. Your Investor Day did a great job in telling why revenues are going to continue to grow through 2025, but obviously, the short-term-ism of the stock market, we want to see what fiscal '22 looks like. And I think I heard your answer there. It's tough to make a call on general education. There's things you don't know at this point, but to a certain extent, career learning and potentially learning solutions is going to help to offset that in fiscal '22. Are there anything -- did I get that right? Or are there other things to be considered for fiscal '22?

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Good morning, David.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
OK, operator. Well, thank you very much. I'd like to thank everybody on the call for your time today, and this completes our presentation.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Good morning, Dara.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Sure. I'll go ahead and I'll start on that Gordon. Right now we expect 60% of our backlog, current backlog to deliver in 2021 and we'll see what other orders come in during the year.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Well, I'll be happy to have Scott and Xia but I will say there are a lot of year ahead including a large quarter in the summer quarter. So we'll have to see, I think, what weather bodes for. I think -- Scott, I think the biggest swing we're looking at potentially is weather in the summer.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
I think you're right. Compared to a lot of companies, we probably have a little bit more pricing flexibility and short-term ordering patterns that will allow us to do that. But I use the word will allow us to do it. Not that we've done it already.
I mean, in some parts of our business, we have increased pricing to reflect increased costs or reduced volume, frankly. And we have blanket agreements with some of our major customers, which are volume dependent and the volumes dropped as part of the whole pandemic effect on the industry. And in some of our parts of our business, we're doing some other kind of innovative things like putting on a temporary surcharge to cover what we think are temporary increases in costs. And that's actually kind of been working, I guess.
We haven't had much pushback on that. So, we're -- we definitely have an eye out for it. But I would tell you that the price increases that we've seen so far are outpacing the opportunities that we have to increase pricing going to our customers. So, over time, that'll all equal out, but it's probably going to be -- hopefully a three or four-month lag, could be a six-month or a year lag before it all kind of balances out.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Thanks. Gross margin increased 40 basis points for Q2 2021 to 28.2%, compared to Q1 2021. We are adding capacity given continuing strong market demand. Our assembly and DDIC high-end test platforms remain near full utilization levels and both ASP increased and high utilization level both led revenue growth and profit improvement. The average price increase from all product lines was about 5% to 6%.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
We are absolutely looking at everything that's in the market. Our pencils will be sharpened, we're underwriting some different actions that are out there. So again, what's been nice is to be able to see the activity we're seeing in the markets. Just having the boots on the ground with our local leasing teams seeing the momentum and the activity in the market, it gives you more confidence if we want to go out and buy the vacancy. So we continue to work -- we update on a quarterly basis. And we're open for business that we can find the right opportunity that's priced appropriately from our standpoint.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
I'll address it first, and then Scott can add in. Obviously, we had margin expansion year over year. I think it was about 80 basis points or so for Sterigenics. The operating model is such that as you get volume coming across these facilities with the fixed cost, you get good operating leverage.
And so as volumes come back versus third, fourth quarter next year, we would expect to see improvements and margin rates expansion.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Hi, Randy. Good. So?

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes, it is.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
I think the timing of sales and the volume of sales, there are a lot of different inputs. One is certainly the position of the particular assets that we're focused on, whether they're fully leased. We're looking to obviously maximize value on those assets. The volumes, I think, going forward, are going to be closer to that $100 million to $150 million range than maybe a few years ago when we were selling $225 million, $240 million.
But that can change. Sometimes we get some unsolicited offers that we can't refuse on assets that maybe we didn't have at the top of our list to dispose of, in which case we'll take that opportunity to dispose of those assets. So yes, we're not going to probably move up the disposition volume like we are. The development pipeline is really the answer to your question.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah, so I'm gonna won't break out the quarters. But yes, there's certainly a an expectation that our even margins are going to be higher this year, our flow through has been great. Our demand obviously has been very high. There is certainly a seasonal nature to what we do. So you know, inevitably you'll see some some nice quarters during the summer when we reach our peak peak utilization and peak leverage. You know, the the nature of our long term, you know, I think we've consistently talked about believing we get the 910 percent EBIT, we're certainly working on that internally every day. And we're in regard to what Dave was talking about on operational excellence, the efficiencies that we think we can bring into this business as industry, you know, through technology through operational improvements through process. So certainly committed to that and believe that in the long run, you know, the dynamics around any given quarter obviously, are a little bit unique, but for this year is going to be an exceptionally strong year, given the combination of high demand and, you know, record prices and certain products.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Thanks for the question. We routinely work with structural engineers and architects and others, as we're doing any work on our properties as well as any work that's being done on adjacent properties and routinely inspect our properties for their 40-year inspections and additionally. And so we have no known issues. We are just in an abundance of caution, going to go back and take another look both to ensure that we haven't missed anything, which I don't think we have, but also just for peace of mind for our residents and teammates, who work in those buildings.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
It's not that easy. Volume-weighted, I would say, it's just inside of five years, would be my guess.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Hi, Frank.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
So Scott, it's -- we always want to be competitively paid, right, so -- be a competitive player. So we put that in place, we put in, we did not have one, a similar one in 2020. However, I would stress that we did add additional sorts of compensation either in paid time off or a one-time bonus to effectively change the compensation mix for drivers last year.
So we put it in place this year, we will continue to focus on competitive pay, so, could we make a change farther into the year? Yeah, it could happen, but that remains to be seen. Ultimately, we know it's inflationary environment out there. We know it's a competitive driver environment. So we have to pay competitively. So we still -- we monitor that pretty closely and we'll make adjustments as we need to into the year.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
So, 1,600 to 1,700 in Q4 is still what more than triple of last year's results. So we are obviously very happy about that. In the fourth quarter, you see the impact of seasonality, people focus their discretionary spending on holiday spend rather than purchasing these cars. So there is some pressure from that point of view on GPU to some extent.
And the last thing I would say is that there is a level of conservatism here just because of the experience we had in previous Q fours, we wanted to make sure that we gave you our best estimate at this point. So that's where we are. The wholesale, I don't think you're going to see a lot of impact of -- or negative impact of wholesale on our numbers in the fourth quarter.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes. Again, very important point. It's very easy to understand today why dev and op came together on a common ground and the IT people and the developers started to find some joint assets to work on and collaborate. If you look at 99% of the organization that we see in the market, what we hear from our customers, what we hear from the community is that security and developers yet didn't find the common ground.
There are pains that the organizations try to protect and there are vulnerabilities that the developers are trying to find before it goes to production. Our challenge, our mission is to make sure that you protect it all the way from the developer hand, from the developer's keyboard to the deployment. And therefore, Vdoo as an addition to Xray, will provide that would provide the common ground between the developer and the security stakeholders of the organization.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Hey, Bryan. It's Dexter. In short, we don't see a slowdown versus if you think about it on Q3, Q4 sequential. I mean, the US -- North American business is holding up well.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
I think we would look at both. Particularly, if we're looking at similar customers that we have, the ability to get a larger share of that customer's wallet, even if it's not a tangential product is something we would consider also.

    Prediction (one of UP, DOWN, SAME): DOWN